Astrobiome
Astrobiome is a Luxembourg-based biotechnology company that develops space-adapted postbiotic supplements, B2B functional ingredients, and agricultural biostimulants from bacterial strains exposed to microgravity aboard the International Space Station. It serves health-conscious consumers, food and beverage brands, and the ag-biotech sector.
- Company typePrivate
- Founded2022
- HeadquartersHouston, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Astrobiome does
Astrobiome (legal entity: Astrobiome Space SARL) is a privately held biotechnology company founded in 2022, headquartered in Luxembourg with operational presence in Houston. The company develops "Super-Postbiotics" — bioactive metabolite formulations built on bacterial strains sourced from centenarian gut microbiota and millenary olive tree microbiomes, then exposed to space environment conditions (microgravity, radiation) aboard International Space Station missions. The platform combines Japanese fermentation mastery with space biotechnology and is underpinned by 25 years of microbiome evolution research inherited from Innovation Labo Sciences.
The company operates three commercial lines: (1) a direct-to-consumer postbiotic supplement business sold through owned e-commerce (astrobiome.space, shop.astrobiome.space) at $195–$245 per month on subscription and $245 / $700 / $2,100 for one-time purchases; (2) a B2B ingredient licensing platform branded "Astrobiome INSIDE," targeting functional beverage and snack brands; and (3) a Beyond Organic agricultural biostimulant positioned in the ag-biotech segment at $250 per unit. The reported output is 300+ bioactive metabolites per formulation.
Astrobiome has assembled a multi-agency space ecosystem — partnerships with NASA, JAXA, ESA, and the Luxembourg Space Agency (including two LuxImpulse grants in 2025 and 2026), and a flagship ISS Commercial Greenhouse mission with Redwire Corporation scheduled for June 2026. The company has won industry recognition annually since 2022, including NutraIngredients Start-up of the Year (2022), the ESA Space Impact Hall of Fame (2023), Top Agri Biotech Solutions Provider (2024), and Most Innovative Microbiome Therapeutics Company from Global Health & Pharma (2025). It hosted the Astrobiome Space Symposium at the Osaka World Expo, indicating Japan/APAC market intent. Founder and CEO Vera Mulyani and Chief Scientist Dr. Bejit Ideas lead the company.
Astrobiome firmographics
Firmographics- Name
- Astrobiome
- Legal name
- Astrobiome Space SARL
- Website
- https://astrobiome.space
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Astrobiome is a Luxembourg-based biotechnology company that develops space-adapted postbiotic supplements, B2B functional ingredients, and agricultural biostimulants from bacterial strains exposed to microgravity aboard the International Space Station. It serves health-conscious consumers, food and beverage brands, and the ag-biotech sector.
- Ownership category
- akta.pro rank
Astrobiome industry classification
Industry- Product category
- Postbiotic Supplements
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Microbiome-Derived Metabolite Therapeutics (postbiotics) (HLAAAFAB)
- akta.pro secondary industries
- Probiotics & Digestive Health Supplements (CRADAGAF), Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)
Keywords
Where Astrobiome is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Astrobiome business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Consumer Supplements: Direct-to-consumer sale of postbiotic supplements in capsule form with subscription and one-time purchase options. Products include 1-month, 3-month, and 1-year treatment packages.
- B2B Ingredient Platform (Astrobiome INSIDE): Licensing/supply of postbiotic metabolites as an advanced ingredient platform for functional beverages, snacks, and children's drinks. Brands can integrate bioactive metabolites without altering taste, texture, or stability.
- Agricultural Biostimulant: Sale of Beyond Organic Biostimulant for plants, derived from space-adapted microbes for soil enhancement applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | 1 Month Treatment - Subscription |
| One time/ perpetual license | Monthly | 1 Month Treatment - One-time |
| One time/ perpetual license | Monthly | 3 Month Treatment |
| One time/ perpetual license | Multi-year contract | 1 Year Family Package |
| Unit Pricing | Pay-as-you-go | Beyond Organic Biostimulant for Plants |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Astrobiome product offering
Product offeringCore offering
Astrobiome produces Super-Postbiotics through a proprietary space-adapted microbiome platform that ferments bacterial strains under microgravity and radiation conditions, generating over 300 bioactive metabolites. The company sells consumer postbiotic supplement capsules directly via its e-commerce storefront and licenses its postbiotic metabolite ingredient to food and beverage brands through the Astrobiome INSIDE B2B platform. It also markets a Beyond Organic Biostimulant for agricultural soil enhancement derived from space-adapted microbes.
Product overview
Astrobiome is a Luxembourg-based biotechnology company that produces Super-Postbiotics™ through a unique process combining Japanese fermentation mastery with space biotechnology. The product portfolio centers on the core Astrobiome® Postbiotics line—daily supplement capsules available in 1-month, 3-month, and 1-year treatment packages (plus subscription options)—containing over 300 bioactive metabolites derived from space-adapted bacterial strains. The company also offers Astrobiome® INSIDE, an ingredient platform enabling third-party brands to integrate these postbiotic compounds into functional beverages and snacks. A complementary product, Beyond Organic Biostimulant® for Plants, applies the company's space-adapted microbe technology to agricultural biostimulants. The products are positioned around microbiome health, longevity, and resilience, derived from strains modeled on super-centenarians and evolved under space conditions.
Differentiator
Problem solved
Functional benefit
Brands
- Astrobiome® INSIDE: An advanced ingredient platform designed to elevate functional beverages and snacks with bioactive metabolites, available in liquid or powder form for brand integration.
- Super-Postbiotics™
Products and services
- Astrobiome Postbiotics Capsules (1-Month Treatment) Daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Available as a 1-month treatment package for individual consumers seeking gut health, immune, and longevity support.
- Astrobiome Postbiotics Capsules (3-Month Treatment) Three-month supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Marketed for sustained microbiome balance, digestive health, and whole-body resilience.
- Astrobiome Postbiotics Capsules (1-Year Family Package) One-year (12-month) supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites, sold as a Family Package for households seeking long-term longevity, vitality, and optimized metabolic support.
- Astrobiome Postbiotics Monthly Subscription Recurring monthly subscription to Astrobiome Postbiotics capsules at a discounted price versus one-time purchase, with automatic ongoing delivery for consumer convenience.
- Astrobiome INSIDE (B2B Ingredient Platform) Advanced ingredient platform supplying postbiotic metabolites in liquid or powder form to functional beverage, snack, and children's drink manufacturers, enabling integration of gut-health and longevity benefits without altering taste, texture, or stability.
- Beyond Organic Biostimulant for Plants Plant biostimulant developed from space-adapted microbes for agricultural soil enhancement applications, including strawberry cultivation in space environments, leveraging the company's microgravity-adapted microorganisms.
Quantifiable outcome
- Blood sugar reduction in Type 2 diabetes patients within 3 days of use
- +3 more outcomes
Companies that use Astrobiome
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Astrobiome technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Astrobiome partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship, core and minor.
- Redwire CorporationflagshipAstrobiome signed contract with Redwire Corporation on June 4, 2026 to launch commercial Greenhouse system aboard the International Space Station for space agriculture research. The mission will grow wild strawberries and test Astrobiome's proprietary soil enhancement biostimulant developed from space-adapted microbes. This marks the world's first commercial space greenhouse, driving significant investor interest and 12-18% stock surge for Redwire.
- Luxembourg Space Agency (LSA)coreLuxembourg Space Agency supports Astrobiome through LuxImpulse grants. Mathias Link, Deputy Director General, highlighted international collaboration with NASA, JAXA, ESA and emphasized how the mission brings together space exploration, agriculture, food security and health with significant commercial opportunities.
- Innovation Labo Sciences, LtdcoreJapan-based microbiome research laboratory. Dr. Bejit Ideas serves as Chief Scientist at Astrobiome Space and inventor at Innovation Labo Sciences. The partnership draws on 25 years of microbiome evolution research conducted at Innovation Labo, the world's first research platform for co-culturing bacteria in extreme environments.
- NinapharmcoreCo-organizer of Astrobiome Space Symposium at the French Pavilion during Osaka World Expo, collaborating with Astrobiome Space SARL and Innovation Labo Sciences on space medicine and longevity microbiome research presentations.
- NASAcoreResearch collaboration with NASA for space biotechnology development. Dr. Jennifer Fogarty, former Chief Scientist of NASA's Human Research Program, participated in Astrobiome Space Symposium. The collaboration enables formulation of postbiotic solutions with exceptional efficacy for space and terrestrial applications.
- JAXA (Japan Aerospace Exploration Agency)coreResearch partnership for space-based microbiome studies. Astronaut Soichi Noguchi, former JAXA astronaut, shared insights from multiple missions and emphasized urgent need for microbial solutions to support long-duration space missions.
- European Space Agency (ESA)coreESA collaboration recognized through Space Impact Hall of Fame award. ESA supports space-based research initiatives that enable Astrobiome's unique production process using microgravity conditions.
- Bonneval WatersminorDavid Merle, CEO of Bonneval Waters, presented at Astrobiome Space Symposium on applying innovative technology to beverages, highlighting potential for integrating advanced microbiological solutions into energy drinks for enhanced health benefits.
- L'Osier Restaurant (Tokyo)minorChef Olivier Chaignon, Executive Chef of 3 Michelin-starred L'Osier, presented concept of microbiological agriculture as new frontier in gastronomy, showing how ingredients cultivated in microbiome-rich environments can enhance nutritional and sensory quality.
- Chocolkan Brain LongevityminorSophie Burrus-Müller, creator of Chocolkan Brain Longevity project, developed dairy-free chocolate drink for memory improvement and brain cell repair using postbiotic integration concepts presented at symposium.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Astrobiome competitors and assessment
Company assessmentDirect peers
- Seed Health: US-based probiotics and microbiome science company selling DTC synbiotic/postbiotic supplements. Comparable target customer (wellness-optimized consumer), premium pricing model, and science-led brand storytelling, with an emerging ingredient platform serving clinical and nutrition partners.
- BIOHM Health: US-based microbiome supplement company offering probiotics, prebiotics, and postbiotic-style digestive formulations. Comparable in product form (capsules), consumer positioning (gut health, weight management), and emphasis on full-spectrum microbiome science.
- Pendulum: US-based DTC microbiome/postbiotic supplement company selling glucose control, metabolic, and gut health products. Closest direct competitor to Astrobiome's capsule-based postbiotic portfolio with similar premium DTC positioning and digestive/metabolic efficacy claims.
Broad incumbents
- Novonesis: Global bioscience major (formed via Novozymes and Chr. Hansen merger) producing food cultures, enzymes, and probiotic/postbiotic ingredients for B2B food, beverage, nutrition, and agriculture markets. Directly comparable to Astrobiome INSIDE on the B2B ingredient side and able to scale postbiotic licensing far beyond what a sub-50-employee startup can serve.
- Lallemand Health Solutions: Canadian-owned global supplier of probiotic and postbiotic ingredients for human and animal nutrition. Comparable as a B2B probiotic/postbiotic fermentation platform serving supplement and F&B brands, with established documentation and regulatory frameworks Astrobiome currently lacks.
- Chr. Hansen (now Novonesis): Legacy probiotic and food-cultures giant (merged into Novonesis) with deep pipeline of human and animal probiotic/postbiotic strains. Comparable on fermentation science, strains derived from human microbiota, and B2B ingredient licensing model.
Emerging players
- AB Biotics: Spain-based probiotics and microbiome ingredient company with proprietary strains and clinical dossiers. Comparable on B2B probiotic ingredient licensing to F&B and supplement brands, and on strain-engineering focus.
- Symbiome: US-based postbiotic personal care and ingestible brand developed from microbiome research. Comparable as a consumer-facing brand built around postbiotic/fermentation-derived bioactives, with premium positioning and category-creation ambitions similar to Astrobiome's.
- Pivot Bio: US-based agricultural microbiome company producing microbial nitrogen-fixing biostimulants for crops. Comparable to Astrobiome's Beyond Organic Biostimulant product on agricultural biostimulant positioning and microbial-input technology, and a credible test case for scaling biological ag inputs to mainstream growers.
- Fitbiomics: Microbiome company translating elite-athlete microbiome research into consumer gut health products. Comparable in microbiome-derived bioactive positioning and use of proprietary strains, though narrower in product scope than Astrobiome's full-spectrum metabolite complex.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Astrobiome social profiles
Digital presenceAstrobiome financial estimates
Financial estimateRevenue estimate
Valuation estimate
Astrobiome leadership team
Management profileNumber of profiles
Profiles2 records
Astrobiome funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Astrobiome M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Astrobiome
What does Astrobiome do?
Astrobiome produces Super-Postbiotics through a proprietary space-adapted microbiome platform that ferments bacterial strains under microgravity and radiation conditions, generating over 300 bioactive metabolites. The company sells consumer postbiotic supplement capsules directly via its e-commerce storefront and licenses its postbiotic metabolite ingredient to food and beverage brands through the Astrobiome INSIDE B2B platform. It also markets a Beyond Organic Biostimulant for agricultural soil enhancement derived from space-adapted microbes.
Is Astrobiome a public or private company?
Astrobiome is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Astrobiome founded?
Astrobiome was founded in 2022. It employs 11 to 50 people.
Where is Astrobiome based?
Astrobiome is headquartered in Houston, United States, in the North America region.
How does Astrobiome make money?
Three revenue lines are on record. Consumer Supplements are the primary driver. The others are B2B Ingredient Platform (Astrobiome INSIDE) and agricultural Biostimulant.
Who are Astrobiome's main competitors?
Direct peers on record are Seed Health, BIOHM Health and Pendulum. Broad incumbents are Novonesis, Lallemand Health Solutions and Chr. Hansen (now Novonesis). Emerging players are AB Biotics, Symbiome, Pivot Bio and Fitbiomics.
Does Astrobiome have an API?
No public API is recorded for Astrobiome.
What industry is Astrobiome in?
Astrobiome's product category is Postbiotic Supplements. Its primary akta.pro industry code is HLAAAFAB, Microbiome-Derived Metabolite Therapeutics (postbiotics), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325414 and its SIC code is 2836.